Press release
CD47 Targeting Therapeutics Market Analysis Highlighting Rapid Expansion Driven by Cancer Treatment Innovations
CD47 Targeting Therapeutics Market
A transmembrane protein called CD47 helps cancer cells survive in various cancer types by glycosylating on the surface of numerous cancer cells. When CD47 binds to the signal-regulatory protein SIRP, it starts an inhibitory signalling pathway in many cancer types that stops malignant cells from being phagocytosed by macrophages. Therefore, blocking the CD47-SIRP signalling pathway can promote macrophage phagocytosis of tumour cells.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1290
The global CD47-targeting therapeutics market growth is driven by several factors, including the increasing utilization of CD47-targeted anti-cancer treatments, an aging population, the high prevalence of various cancer types, and growing public awareness of the benefits associated with these therapies.
Over the forecast period, escalating research and development investments aimed at better understanding CD47-dependent signaling are expected to create new opportunities within the market. Enhanced knowledge in this field may facilitate the development of innovative anti-cancer therapies that inhibit CD47 signaling in malignant cells. However, market expansion may be hindered by challenges such as the high production costs and manufacturing complexities of targeted therapies, potential off-target effects damaging healthy cells, and stringent regulatory requirements for therapeutic approvals.
Regionally, North America is projected to be a significant contributor to the CD47-targeting therapeutics market throughout the forecast period, driven by rising cancer incidence and mortality rates, along with the rapid adoption of novel drugs and treatment modalities. The United States, in particular, plays a pivotal role by supporting extensive research and development initiatives focused on CD47-targeted therapies. Concurrently, the Asia Pacific market is anticipated to experience substantial growth, fueled by increasing use of CD47-targeting anti-cancer therapies, a growing elderly population, the high burden of diverse cancer types, and heightened awareness of the therapeutic advantages offered by CD47 inhibition in the region.
Major market players operating in the CD47 Targeting Therapeutics market include
Conjupro biotherapeutics (US), EpicentRx (US), Forty Seven (US), ImmuneOncia Therapeutics (Korea), ImmuneOnco Biopharmaceuticals (China), Innovent Biologics (China), KAHR Medical (Israel), TG Therapeutics, Adagene, Alector, Inc., Apmonia Therapeutics, I-MAB Biopharma Co., Ltd., Light Chain Bioscience (Switzerland), Morphiex (US), Trillium Therapeutics (Canada), QLSF Biotherapeutics Inc., Phanes Therapeutics, Inc., Bio-Thera Solutions, others.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02
Recent collaborations and agreements in the market:
• In January 2022, the next-generation CD47 blocker evorpacept, manufactured by ALX Oncology, was accorded orphan drug designation ("ODD") for treating patients with gastroesophageal junction and gastric cancer.
• In September 2021, for US$2.3 billion, Pfizer Inc. (US) purchased Trillium Therapeutics Inc. (Canada), which had CD47 prospects. Pfizer now has a stronger cancer and hematology portfolio thanks to this acquisition.
• In June 2021, to test the efficacy of combining ALX148, a next-generation CD47 blocker, and CYRAMZA (ramucirumab), Lilly's anti-VEGFR2 antibody, for the treatment of gastric cancer, ALX Oncology (US) and Eli Lilly and Company (US) agreed into a clinical study partnership and supply agreement.
Market Segments
Global CD47 Targeting Therapeutics Market, by Target Disease Indication, 2022-2030 (Value US$ Mn)
• Acute Myeloid Leukemia
• Non-Hodgkin Lymphoma
• Colorectal Cancer
• Diffuse Large B-cell Lymphoma
• Myelodysplastic Syndromes
• Non-Small Cell Lung Cancers
• Ovarian Epithelial Cancer
• Oral mucositis
• Small Cell Lung Cancers
• Other Diseases Indications
Unlock Your GTM Strategy:https://www.insightaceanalytic.com/customisation/1290
Global CD47 Targeting Therapeutics Market, by Type of Molecule, 2022-2030 (Value US$ Mn)
• Biologics
• Small Molecule
Global CD47 Targeting Therapeutics Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America CD47 Targeting Therapeutics Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe CD47 Targeting Therapeutics Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific CD47 Targeting Therapeutics Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America CD47 Targeting Therapeutics Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa CD47 Targeting Therapeutics Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
o Rest of Middle East & Africa
Why should buy this report:
To receive a comprehensive analysis of the prospects for the global CD47 Targeting Therapeutics market
To receive an industry overview and future trends in the CD47 Targeting Therapeutics market
To analyze the CD47 Targeting Therapeutics market drivers and challenges
To get information on the CD47 Targeting Therapeutics market value (US$Mn) forecast to 2030
Significant investments, mergers & acquisitions in the CD47 Targeting Therapeutics market industry
Read Overview Report- https://www.insightaceanalytic.com/report/global-cd47-targeting-therapeutics-market-/1290
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release CD47 Targeting Therapeutics Market Analysis Highlighting Rapid Expansion Driven by Cancer Treatment Innovations here
News-ID: 4111529 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
6G Market expected to Witness Huge Revenue Growth to 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global 6G Market Size, Share & Trends Analysis Report By Devices (Mobile Devices, IoT and Edge-Computing Devices, Networking Devices), Communication Infrastructure (Wireless And Fixed) And End Users (Consumer Applications And Industrial And Enterprise)- Market Outlook And Industry Analysis 2035"
The global 6G market is estimated to reach over USD 159.54 billion by 2035, exhibiting a CAGR of…
5G Non-Terrestrial Networks Market Current Scenario with Future Trends Analysis …
"5G Non-Terrestrial Networks Market" in terms of revenue was estimated to be worth $ 5.5 billion in 2024 and is poised to reach $192.0 billion by 2034, growing at a CAGR of 43.1% from 2025 to 2034 according to a new report by InsightAce Analytic.
Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1921
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the 5G non-terrestrial networks market are:
• Technological advancement
• High network…
Over The Counter Tests Market Exclusive Report on Current Trends and Future Insi …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Over The Counter Tests Market Size, Share & Trends Analysis Report By Technology (Lateral Flow Assays, Immunoassays, Dipsticks), By Product (Infectious Disease Tests, Glucose Monitoring Tests, Pregnancy and Fertility Tests), Region, Market Outlook And Industry Analysis 2031"
The Global Over The Counter Tests Market is estimated to reach over USD 43.40 billion by 2031, exhibiting a…
Artificial Intelligence in Cardiology Market is on an Upward Growth Curve
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Artificial Intelligence in Cardiology Market Size, Share & Trends Analysis Report By Component (Hardware, Services), By Application (Stroke, CHD/CAD), Region, Market Outlook And Industry Analysis 2031"
The global artificial intelligence in cardiology market is estimated to reach over USD 11.5 billion by 2031, exhibiting a CAGR of 32.70% during the forecast period.
Request For Free Sample…
More Releases for CD47
Anti-CD47 Drugs Market to Set Phenomenal Growth From 2025 to 2034
CD47, a cell surface glycoprotein, plays a critical role in regulating immune responses and cell signaling. Often referred to as the "don't eat me" signal, CD47 interacts with its receptor, SIRPα (signal regulatory protein alpha), on macrophages and other immune cells to inhibit phagocytosis, or the process by which immune cells engulf and destroy foreign or damaged cells. Many cancer cells overexpress CD47, which helps them evade immune detection and…
CD47 Targeting Therapeutics Market Robust Expansion is expected to 2034
CD47 Targeting Therapeutics Market Future Pipeline/Clinical Trial Analysis and Revenue Forecast Snapshot - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "CD47 Targeting Therapeutics Market By Target Disease Indication (Acute Myeloid Leukemia, Non-Hodgkin Lymphoma, Colorectal Cancer, Diffuse Large B-cell Lymphoma, Myelodysplastic Syndromes, Non-Small Cell Lung Cancers, Ovarian Epithelial Cancer, Oral mucositis, Small Cell Lung Cancers, Other Diseases Indications), By…
CD47 Targeting Therapeutics Market Investments, Share and Revenue Analysis Repor …
CD47 Targeting Therapeutics Market Future Pipeline/Clinical Trial Analysis and Revenue Forecast Snapshot - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "CD47 Targeting Therapeutics Market By Target Disease Indication (Acute Myeloid Leukemia, Non-Hodgkin Lymphoma, Colorectal Cancer, Diffuse Large B-cell Lymphoma, Myelodysplastic Syndromes, Non-Small Cell Lung Cancers, Ovarian Epithelial Cancer, Oral mucositis, Small Cell Lung Cancers, Other Diseases Indications), By…
CD47 Targeting Therapeutics Market Future Trends and Scope Analysis Report
Insight Analytics Pvt. Ltd. announces the release of a market assessment report on the "Global CD47 Targeting Therapeutics Market- by Target Disease Indication (Acute Myeloid Leukemia, Non-Hodgkin Lymphoma, Colorectal Cancer, Diffuse Large B-cell Lymphoma, Myelodysplastic Syndromes, Non-Small Cell Lung Cancers, Ovarian Epithelial Cancer, Oral mucositis, Small Cell Lung Cancers and Other Diseases Indications), Type of Molecule (Biologics and Small Molecule), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
According to…
Future Directions in CD47 Research: Innovations and Clinical Translation
CD47, a protein that plays a critical role in immune evasion by tumor cells, has emerged as a key target in cancer research. Its ability to interact with signal regulatory protein alpha (SIRPα) on macrophages, delivering a "don't eat me" signal that prevents the phagocytosis of tumor cells, has made it a focal point for therapeutic development. As research into CD47 progresses, several innovative approaches and clinical translation efforts are…
CD47 Targeting Therapeutics Market Future Trends and Scope Analysis Report
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "Global CD47 Targeting Therapeutics Market By Target Disease Indication (Acute Myeloid Leukemia, Non-Hodgkin Lymphoma, Colorectal Cancer, Diffuse Large B-cell Lymphoma, Myelodysplastic Syndromes, Non-Small Cell Lung Cancers, Ovarian Epithelial Cancer, Oral mucositis, Small Cell Lung Cancers, Other Diseases Indications), By Type of molecule(Biologics, Small molecule) - Market Outlook and Industry Analysis 2030"
According to the latest research…
